Literature DB >> 26355158

IFN-γ Prevents Adenosine Receptor (A2bR) Upregulation To Sustain the Macrophage Activation Response.

Heather B Cohen1, Amanda Ward1, Kajal Hamidzadeh1, Katya Ravid2, David M Mosser3.   

Abstract

The priming of macrophages with IFN-γ prior to TLR stimulation results in enhanced and prolonged inflammatory cytokine production. In this study, we demonstrate that, following TLR stimulation, macrophages upregulate the adenosine 2b receptor (A2bR) to enhance their sensitivity to immunosuppressive extracellular adenosine. This upregulation of A2bR leads to the induction of macrophages with an immunoregulatory phenotype and the downregulation of inflammation. IFN-γ priming of macrophages selectively prevents the induction of the A2bR in macrophages to mitigate sensitivity to adenosine and to prevent this regulatory transition. IFN-γ-mediated A2bR blockade leads to a prolonged production of TNF-α and IL-12 in response to TLR ligation. The pharmacologic inhibition or the genetic deletion of the A2bR results in a hyperinflammatory response to TLR ligation, similar to IFN-γ treatment of macrophages. Conversely, the overexpression of A2bR on macrophages blunts the IFN-γ effects and promotes the development of immunoregulatory macrophages. Thus, we propose a novel mechanism whereby IFN-γ contributes to host defense by desensitizing macrophages to the immunoregulatory effects of adenosine. This mechanism overcomes the transient nature of TLR activation, and prolongs the antimicrobial state of the classically activated macrophage. This study may offer promising new targets to improve the clinical outcome of inflammatory diseases in which macrophage activation is dysregulated.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26355158      PMCID: PMC4686143          DOI: 10.4049/jimmunol.1501139

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage.

Authors:  A Ohta; M Sitkovsky
Journal:  Nature       Date:  2001 Dec 20-27       Impact factor: 49.962

2.  Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms.

Authors:  G Haskó; D G Kuhel; J F Chen; M A Schwarzschild; E A Deitch; J G Mabley; A Marton; C Szabó
Journal:  FASEB J       Date:  2000-10       Impact factor: 5.191

3.  Biochemical and functional characterization of three activated macrophage populations.

Authors:  Justin P Edwards; Xia Zhang; Kenneth A Frauwirth; David M Mosser
Journal:  J Leukoc Biol       Date:  2006-08-11       Impact factor: 4.962

Review 4.  Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation.

Authors:  Xiaoyu Hu; Janice Chen; Lu Wang; Lionel B Ivashkiv
Journal:  J Leukoc Biol       Date:  2007-05-14       Impact factor: 4.962

5.  Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.

Authors:  R Ito; M Shin-Ya; T Kishida; A Urano; R Takada; J Sakagami; J Imanishi; M Kita; Y Ueda; Y Iwakura; K Kataoka; T Okanoue; O Mazda
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

6.  HIF-dependent induction of adenosine A2B receptor in hypoxia.

Authors:  Tianqing Kong; Karen A Westerman; Marion Faigle; Holger K Eltzschig; Sean P Colgan
Journal:  FASEB J       Date:  2006-11       Impact factor: 5.191

7.  B-Myb regulates the A(2B) adenosine receptor in vascular smooth muscle cells.

Authors:  Cynthia St Hilaire; Dan Yang; Barbara M Schreiber; Katya Ravid
Journal:  J Cell Biochem       Date:  2008-04-15       Impact factor: 4.429

8.  The expression of heparin-binding epidermal growth factor-like growth factor by regulatory macrophages.

Authors:  Justin P Edwards; Xia Zhang; David M Mosser
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

9.  Adenosine, adenosine receptors and their role in glucose homeostasis and lipid metabolism.

Authors:  Milka Koupenova; Katya Ravid
Journal:  J Cell Physiol       Date:  2013-03-04       Impact factor: 6.384

10.  TNF-alpha upregulates the A2B adenosine receptor gene: The role of NAD(P)H oxidase 4.

Authors:  Cynthia St Hilaire; Milka Koupenova; Shannon H Carroll; Barbara D Smith; Katya Ravid
Journal:  Biochem Biophys Res Commun       Date:  2008-07-21       Impact factor: 3.575

View more
  13 in total

Review 1.  Targeting CD39 in cancer.

Authors:  Achim K Moesta; Xian-Yang Li; Mark J Smyth
Journal:  Nat Rev Immunol       Date:  2020-07-29       Impact factor: 53.106

Review 2.  Targeting A2 adenosine receptors in cancer.

Authors:  David Allard; Martin Turcotte; John Stagg
Journal:  Immunol Cell Biol       Date:  2017-02-08       Impact factor: 5.126

Review 3.  The adenosine pathway in immuno-oncology.

Authors:  Bertrand Allard; David Allard; Laurence Buisseret; John Stagg
Journal:  Nat Rev Clin Oncol       Date:  2020-06-08       Impact factor: 66.675

Review 4.  Macrophages and the Recovery from Acute and Chronic Inflammation.

Authors:  Kajal Hamidzadeh; Stephen M Christensen; Elizabeth Dalby; Prabha Chandrasekaran; David M Mosser
Journal:  Annu Rev Physiol       Date:  2016-12-07       Impact factor: 19.318

5.  Editorial: Macrophages Role in Integrating Tissue Signals and Biological Processes in Chronic Inflammation and Fibrosis.

Authors:  Tarcio Teodoro Braga; Ivan C Moura; Ana Paula Lepique; Niels Olsen Saraiva Camara
Journal:  Front Immunol       Date:  2017-07-21       Impact factor: 7.561

Review 6.  Adenosine Signaling in Mast Cells and Allergic Diseases.

Authors:  Lucia Garcia-Garcia; Laia Olle; Margarita Martin; Jordi Roca-Ferrer; Rosa Muñoz-Cano
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

Review 7.  ATP and cancer immunosurveillance.

Authors:  Oliver Kepp; Lucillia Bezu; Takahiro Yamazaki; Francesco Di Virgilio; Mark J Smyth; Guido Kroemer; Lorenzo Galluzzi
Journal:  EMBO J       Date:  2021-06-14       Impact factor: 14.012

Review 8.  Purinergic Signaling to Terminate TLR Responses in Macrophages.

Authors:  Kajal Hamidzadeh; David M Mosser
Journal:  Front Immunol       Date:  2016-03-02       Impact factor: 7.561

Review 9.  A2B Adenosine Receptor and Cancer.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Int J Mol Sci       Date:  2019-10-17       Impact factor: 5.923

Review 10.  On the mechanism of anti-CD39 immune checkpoint therapy.

Authors:  David Allard; Bertrand Allard; John Stagg
Journal:  J Immunother Cancer       Date:  2020-02       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.